![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HCV TARGET - Impact of Age on Safety and Treatment Response in Patients with Hepatitis
|
|
|
Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
AAronsohn, T Stainbrook, S Mohanty, A Mubarak, J Spivey, P Prashant, T Stewart, MW Fried, I Jacobson
for the HCV-TARGET Study Group
![AASLD1.gif](../images/111313/111313-2/AASLD1.gif)
![AASLD2.gif](../images/111313/111313-2/AASLD2.gif)
![AASLD3.gif](../images/111313/111313-2/AASLD3.gif)
![AASLD4.gif](../images/111313/111313-2/AASLD4.gif)
![AASLD5.gif](../images/111313/111313-2/AASLD5.gif)
![AASLD6.gif](../images/111313/111313-2/AASLD6.gif)
![AASLD7.gif](../images/111313/111313-2/AASLD7.gif)
![AASLD8.gif](../images/111313/111313-2/AASLD8.gif)
![AASLD9.gif](../images/111313/111313-2/AASLD9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|